The Sci-Tech Innovation Board series indices are strengthening. the Sci-Tech 200 ETF E Fund (588270) and the Sci-Tech 50 ETF E Fund (588080) closely track the Sci-Tech Innovation Board series indices.

NightAirdropper · 2026-03-27T00:00:20+00:00

As of the close, the STAR 50 Index rose by 3.6%, the STAR Composite Index increased by 3.2%, the STAR Growth Index gained 3.0%, the STAR 50 Index went up by 2.3%, and the STAR 100 Index increased by 2.2%. In the market, the semiconductor sector rebounded, with Muxi Co., Ltd. and Saiwei Microelectronics rising over 13%; PCB concept stocks increased, with Nanya New Materials up over 18% and Dongwei Technology up over 10%; the biomedical sector rose, with Bai'ao Saitu up over 10%, and Bide Medical, Sunshine Nuohe, and Haoyuan Medical up over 8%.Wind data shows that as of yesterday, the STAR 50 ETF E Fund (588080, Connect Fund A/C/Y: 011608/011609/022895) has experienced net capital inflows for three consecutive trading days, totaling 740 million yuan.Risk reminder: Funds are subject to risks; investments should be made cautiously.

NightAirdropper

2026-03-27 00:00:20

As of the close, the STAR Market 200 Index rose 3.6%, the STAR Market Composite Index increased 3.2%, the STAR Market Growth Index gained 3.0%, the STAR 50 Index went up 2.3%, and the STAR 100 Index increased 2.2%. In the market, the semiconductor sector rebounded, with Muxi Co., Ltd. and Saiwei Microelectronics rising over 13%; PCB concept stocks increased, with Nanya New Materials up over 18% and Dongwei Technology up over 10%; the biomedical sector also rose, with Bai’ao Saitu up over 10%, and Bide Pharmaceutical, Sunshine Nuohe, and Haoyuan Medical each up over 8%.

Wind data shows that as of yesterday, the STAR 50 ETF E Fund (588080, Connect Fund A/C/Y: 011608/011609/022895) has experienced net capital inflows for three consecutive trading days, totaling 740 million yuan.

Risk reminder: Funds are risky; investments should be made cautiously.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.